UAntwerp and Université libre de Bruxelles (ULB) collaborating in a unique project to accelerate vaccine development

May 11th 2020


Belgium invests in contained facility and laboratories for testing vaccines.

Developing vaccines for unknown pathogens and testing their efficacy is one of the most important challenges facing the global community today. The Belgian Federal Government is investing 20 million euros in a contained facility and laboratories for ‘human challenge’ studies, a major tool in the vaccine development process. The University of Antwerp and the Université libre de Bruxelles will join forces for this unique project.  Please discover the press release here.